Hospitals start company to fight shortages, rising costs of generic drugs

Hospitals start company to fight shortages, rising costs of generic drugs

Sept. 6 (UPI) — Hospitals have come together to form a nonprofit company, Civica Rx, to combat generic drug shortages and rising prices, the new venture said Thursday. Utah-based hospital system Intermountain Healthcare announced in January it planned to form a nonprofit company to make generic medications to address “unwarranted shortages and high costs of […]

New tuberculosis medicines prove more effective in treating resistant strains of TB, with new findings leading to …

Montreal – Several new medicines have been found to be more effective than traditional ones used to treat multidrug-resistant tuberculosis (MDR-TB), according to a new international collaborative study led by Dr. Dick Menzies, senior scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal. These findings precipitated a complete overhaul of worldwide […]

How Tesaro Hopes to Tackle Lung Cancer

How Tesaro Hopes to Tackle Lung Cancer

Tesaro, Inc. (NASDAQ:TSRO) markets a highly successful therapy for ovarian cancer, Zejula, and its plans for the future include winning approval of Zejula’s use alongside another one of its drugs, TSR-042, in non-small cell lung cancer. Will this combination therapy reshape how oncologists treat lung cancer? A one-two punch Zejula is a poly ADP-ribose polymerase (PARP) inhibitor that […]

Countries Should Study, Develop New Approaches To Address Medicine Supply Chain Challenges

Countries Should Study, Develop New Approaches To Address Medicine Supply Chain Challenges

Countries Should Study, Develop New Approaches To Address Medicine Supply Chain Challenges Sep 07, 2018 Hindustan Times: Overhaul the medicine supply chainNachiket Mor, director of the Bill & Melinda Gates Foundation’s India Country Office, and Prashant Yadav, strategy leader for Supply Chain at the Gates Foundation “Health systems around the world are benefiting from recent advances […]

ORILISSA (elagolix) for the Treatment of Pain Associated with Endometriosis

ORILISSA (elagolix) for the Treatment of Pain Associated with Endometriosis

ORILISSA (elagolix) is an oral gonadotropin-releasing hormone (GnRH) antagonist indicated for the treatment of moderate-to-severe pain associated with endometriosis. One of the first drugs to be approved for the condition, ORILISSA was discovered by Neurocrine Biosciences and developed in collaboration with biopharmaceutical company AbbVie under a collaboration and license agreement signed in June 2010. AbbVie […]

The Impact Of The Revolutionary I-SPY 2 TRIAL On Early Stage, High-Risk Breast Cancer Treatment: The Future Of …

The Impact Of The Revolutionary I-SPY 2 TRIAL On Early Stage, High-Risk Breast Cancer Treatment: The Future Of …

WHAT: For almost a century, the randomized clinical trial (RCT) has been the principal tool driving the development of new and better medical treatments. However, realizing the promise of precision medicine requires a profound shift in our approach to clinical research with improved tools, new conventions for assessment, and a modernized system for approvals that […]

Pain Drug Delivery Market 2018- Global Industry Analysis, By Key Players, Segmentation, Trends And Forecast By 2025

“Pain Drug Delivery Market 2018rnrn” Pain Drug Delivery – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025 Pain Drug Delivery Market 2018 Wiseguyreports.Com Adds “Pain Drug Delivery – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Description:  This report […]

Pharma company funding nonprofit's over-the-counter naloxone

Pharma company funding nonprofit's over-the-counter naloxone

By Paul SchottThe Stamford Advocate STAMFORD, Conn. — Purdue Pharma, the embattled maker of OxyContin, announced Wednesday a $3.42 million grant to support a nonprofit pharmaceutical company’s development of an over-the-counter form of naloxone, a drug that can reverse the effects of opioid overdoses. The Stamford-based company’s funding would help Pittsburgh-based Harm Reduction Therapeutics accelerate […]

Hospitals create drug firm

Hospitals create drug firm

TRENTON, N.J. – Several major hospital groups Thursday launched their own generic drug company to tackle chronic shortages and high prices. The new company, Civica Rx, plans to start with 14 widely used hospital drugs long in short supply. The company isn’t disclosing the drugs’ names for competitive reasons, but they include a mix of […]